Stimulation of bacterial adherence by neutrophil defensins varies among bacterial species but not among host cell types

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 2, 2000, Pages 105-111

  Gorter, Annelies D ^a,b   Hiemstra, Pieter S ^c   van Wetering, Sandra ^c   de Bentzmann, Sophie ^d   Dankert, Jacob ^b   van Alphen, Loek ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HÔPITAL MAISON BLANCHE   (France)

Author keywords

Adhesion; Colonization; Lactobacilli; Oral adjuvant

Indexed keywords

DEFENSIN;

ARTICLE; BACTERIUM ADHERENCE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; MORAXELLA CATARRHALIS; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; TARGET CELL;

BACTERIAL ADHESION; BRONCHI; CELL LINE; COLONY COUNT, MICROBIAL; DEFENSINS; EPITHELIAL CELLS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MICROSCOPY, ELECTRON, SCANNING; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIA MENINGITIDIS; PROTEINS; PSEUDOMONAS AERUGINOSA; SPECIES SPECIFICITY; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034212895     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2000.tb01463.x     Document Type: Article

References (24)

1. Todryk S.M., Kelly C.G., Lehner T. Effect of route of immunisation and adjuvant on T and B cell epitope recognition within streptococcal antigen. Vaccine. 16:1998;174-180.
2. Thomas N.W., Jenkins P.G., Howard K.A., Smith M.W., Lavelle E.C., Holland J., Davis S.S. Particle uptake and translocation across epithelial membranes. J. Anat. 189:1996;487-490.
3. Mirchamsy H., Manhouri H., Hamedi M., Ahaurai P., Fateh G., Hamzeloo Z. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections. Biologicals. 24:1996;343-350.
4. Chatfield S., Roberts M., Londono P., Cropley I., Douce G., Dougan G. The development of oral vaccines based on live attenuated Salmonella strains. FEMS Immunol. Med. Microbiol. 7:1993;1-7.
5. Barry E.M., Gomez-Duarte O., Chatfield S., Ruppuoli R., Pizza M., Losonsky G., Galen J., Levine M.M. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infect. Immun. 64:1996;4172-4181.
6. Pouwels P.H., Leer R.J., Boersma W.J. The potential of Lactobacillus as a carrier for oral immunisation: development and preliminary characterization of vector systems for targeted delivery of vaccines. J. Biotechnol. 44:1996;183-192.
7. Claassen E., Van Winsen R., Posno M., Boersma W.J. New and safe 'oral' live vaccines based on Lactobacillus. Adv. Exp. Med. Biol. 317B:1995;1553-1558.
8. Wells J.M., Robinson K., Chamberlain L.M., Schofield K.M., Le Page R.W. Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek Int. J. Gen. Mol. Microbiol. 70:1996;317-330.
9. Mercenier, A. (1999) Lactic acid bacteria as live vaccines. In: Probiotics: A Critical Review (Tannock, G.W., Ed.), pp. 113-128. Horizon Scientific Press, Wymondham.
10. Hone D.M., Harris A.M., Chatfield S., Dougan G., Levine M.M. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine. 9:1991;810-816.
11. Aguirre M., Collins K. Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75:1993;95-107.
12. Adams M.R., Marteau P. On the safety of lactic acid bacteria from food. Int. J. Food Microbiol. 27:1995;263-264.
13. McCracken, V.J. and Gaskins H.R. (1999) Lactic acid bacteria as live vaccines. In: Probiotics: A Critical Review (Tannock, G.W., Ed.), pp. 85-112. Horizon Scientific Press, Wymondham.
14. Namba Y., Hidaka Y., Taki K., Morimoto T. Effect of oral administration of lysozyme or digested bacterial cells walls on immunostimulation in guinea pigs. Infect. Immun. 31:1981;580-583.
15. Gibson, S.A.W. and Conway, P. (1994) Recovery of a probiotic organism from human feces after oral dosing. In: Human Health, The Contribution of Microorganisms (Gibson, S.A.W., Ed.), pp. 119-144. Springer, London.
16. Efthymiou C., Hansen P.A. Antigenic analysis of Lactobacillus acidophilus. J. Infect. Dis. 110:1962;258-267.
17. Henriksson A., Szewzyk R., Conway P.L. Characteristics of the adhesive determinants of Lactobacillus fermentum 104. Appl. Env. Microbiol. 57:1991;499-502.
18. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera-B subunit as oral mucosal adjuvant and antigen vector systems. Vaccine. 11:1993;1179-1184.
19. Leenaars P.P., Hendrikson C.F., Koedam M.A., Claassen I., Claassen E. Comparison of adjuvants for immune potentiating properties and side effects in mice. Vet. Immunol. Immunopathol. 48:1995;123-138.
20. Perdigon G., Alvarez S., Pesce de Ruiz Holgado A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J. Dairy Sci. 58:1991;485-496.
21. Takahashi T., Oka T., Iwana K., Kuwata T., Yamamoto Y. Immune response of mice to orally administered lactic acid bacteria. Biosci. Biotech. Biochem. 57:1993;1557-1560.
22. Fang H., Elina T., Heikki A., Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29:2000;47-52.
23. Chen P., Isomaki P., Rimpilainen M. Human cytokine responses induced by Gram-positive cell walls of normal intestinal microbiota. Clin. Exp. Immunol. 118:1999;261-267.
24. Maassen C.B., van Holten J.C., Balk F., Heijneden Bak-Glashouwer M.J., Leer R., Laman J.D., Boersma W.J., Classen E. Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet. Q. 20:1998;S81-S83.